123 related articles for article (PubMed ID: 16102728)
41. [Regulation of transcription in the Wnt signaling pathway].
Yamashina K; Kikuchi A
Tanpakushitsu Kakusan Koso; 2004 Aug; 49(10):1421-7. PubMed ID: 15346893
[No Abstract] [Full Text] [Related]
42. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
[TBL] [Abstract][Full Text] [Related]
43. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus.
Hu P; Berkowitz P; O'Keefe EJ; Rubenstein DS
J Invest Dermatol; 2003 Aug; 121(2):242-51. PubMed ID: 12880414
[TBL] [Abstract][Full Text] [Related]
44. beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention.
Clapper ML; Coudry J; Chang WC
Mutat Res; 2004 Nov; 555(1-2):97-105. PubMed ID: 15476853
[TBL] [Abstract][Full Text] [Related]
45. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
Suriano G; Vrcelj N; Senz J; Ferreira P; Masoudi H; Cox K; Nabais S; Lopes C; Machado JC; Seruca R; Carneiro F; Huntsman DG
Genes Chromosomes Cancer; 2005 Mar; 42(3):238-46. PubMed ID: 15609344
[TBL] [Abstract][Full Text] [Related]
46. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of the DNA binding by the TCF-1 binding RNA aptamer.
Park MW; Choi KH; Jeong S
Biochem Biophys Res Commun; 2005 Apr; 330(1):11-7. PubMed ID: 15781225
[TBL] [Abstract][Full Text] [Related]
48. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
Rios-Doria J; Kuefer R; Ethier SP; Day ML
Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells.
Veeramachaneni NK; Kubokura H; Lin L; Pippin JA; Patterson GA; Drebin JA; Battafarano RJ
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):92-8. PubMed ID: 14752418
[TBL] [Abstract][Full Text] [Related]
50. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
Salins P; Shawesh S; He Y; Dibrov A; Kashour T; Arthur G; Amara F
Neurosci Lett; 2007 Feb; 412(3):211-6. PubMed ID: 17234346
[TBL] [Abstract][Full Text] [Related]
51. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
52. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
53. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
54. Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.
Espada J; Peinado H; Esteller M; Cano A
Exp Cell Res; 2005 May; 305(2):409-17. PubMed ID: 15817165
[TBL] [Abstract][Full Text] [Related]
55. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment.
Chakladar A; Dubeykovskiy A; Wojtukiewicz LJ; Pratap J; Lei S; Wang TC
Biochem Biophys Res Commun; 2005 Oct; 336(1):190-6. PubMed ID: 16139800
[TBL] [Abstract][Full Text] [Related]
56. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
57. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
58. "Decisions, decisions.": beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells.
Wu L; Strasser A
Nat Immunol; 2001 Sep; 2(9):823-4. PubMed ID: 11526393
[No Abstract] [Full Text] [Related]
59. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
60. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
